The Use and Safety Risk of Repurposed Drugs for COVID-19 patients: Lessons Learned Utilizing the Food and Drug Administrations Adverse Event Reporting System https://www.medrxiv.org/content/10.1101/2022.12.10.22283298
The Use and Safety Risk of Repurposed Drugs for COVID-19 patients: Lessons Learned Utilizing the Food and Drug Administrations Adverse Event Reporting System https://www.medrxiv.org/content/10.1101/2022.12.10.22283298